Last updated: December 30, 2013
Sponsor: Ankara Education and Research Hospital
Overall Status: Trial Status Unknown
Phase
3
Condition
Neurologic Disorders
Peripheral Neuropathy
Treatment
N/AClinical Study ID
NCT02024191
031
Ages 20-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age between 20 - 65 years
Operated and non operated colorectal cancer patients
Patient administering mFOLFOX 6 ( Folinic acid 400 mg/m2 1 day, oxaliplatin 85 mg/m2 1day, 5-fluorouracil 400 mg/m2 bolus 2400 mg/m2 continuous infusion 48 hours)
Exclusion
Exclusion Criteria:
Patients who had chemotherapy in last 6 months
Diabetes Mellitus
Sensorimotor polyneuropathy
Anemia
Study Design
Total Participants: 80
Study Start date:
December 01, 2013
Estimated Completion Date:
June 30, 2015
Study Description
Connect with a study center
Ankara Numune Education and Research Hospital
Ankara, 06230
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.